Leukemia vaccine: Sellas Life Sciences reduces death risk by 41%
The biotech company Sellas Life Sciences has announced encouraging results for its therapeutic vaccine against acute myeloid leukemia.
Published 1h1 sourceNotable
Lire en français
≈ 11s
Click the link to read an article on the topic: